Antioxidant enzyme gene expression in rats with remnant kidney induced chronic renal failure

Experimental Nephrology

Volumn 8, Issue 2, 2000, Pages 91-96

  Van Den Branden, Christiane ^a,b   Ceyssens, Bart ^a   De Craemer, Dirk ^a   De Bleser, Pieter ^a   Hellemans, Karine ^a   Geerts, Albert ^a   Verbeelen, Dierik ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Antioxidant enzymes; Catalase; Gene expression; Glomerulosclerosis; Glutathione peroxidase; Remnant kidney; Superoxide dismutase

Indexed keywords

ANTIOXIDANT; CATALASE; GLUTATHIONE PEROXIDASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; GENE EXPRESSION; GLOMERULOSCLEROSIS; MALE; NEPHRECTOMY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

EID: 0034065749     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020654     Document Type: Article

References (25)

1. Rodemann HP, Binder A, Burger A, Güven N, Loffler H, Bamberg M: The underlying cellular mechanism of fibrosis. Kidney Int 1996; 49(suppl 54):32-36.
2. Schnapper HW, Kopp JB, Poncelet AC, Hubchak SC, Stetler-Stevenson WG, Klotman PE, Kleinmann HK: Increased expression of extracellular matrix protein and decreased expression of matrix protease after serial passage of glomerular mesangial cells. J Cell Sci 1996;109: 521-528.
3. Okada H, Strutz F, Danoff IM, Neilson EG: Possible pathogenesis of renal fibrosis. Kidney Int 1996;49(suppl 54):37-38.
4. Muchaneta-Kubara EC, El Nahas AM: Myofibroblast phenotype expression in experimental scarring. Nephrol Dial Transplant 1977;12: 904-915.
5. Bohle A, Mackensen-Haen S, von Gise H, Grung KE, Wehrman M, Batz C, Bogenschütz O, Schmitt H, Nagy J, Müller C: The consequences of tubulo-interstitial changes for renal function in glomerulopathies: A morphometric and cytological analysis. Pathol Res Pract 1990;186:135-144.
6. Vleming LJ, Daelde JJ, Westendorp RGJ, Daha MR, van Es LA, Brujin JA: The glomerular deposition of PAS-positive material correlates with renal function in human kidney disease. Clin Nephrol 1997;47:158-167.
7. McCartey MF: A central role for protein kinase C overactivity in diabetic glomerulosclerosis: Implications for prevention with antioxidants, fish oil, and ACE inhibitors. Med Hypotheses 1998;50:155-165.
8. Studer RK, Craven PA, De Rubertis FR: Antioxidant inhibition of protein kinase C-signaled increases in transforming growth factor-beta in mesangial cells. Metabolism 1997;46: 918-925.
9. Yoshioka T, Bills T, Moore-Jarretl T, Greene HL, Burr IM, Ichikawa I: Role of intrinsic antioxidant enzymes in renal oxidant injury. Kidney Int 1990;38:282-288.
10. Gwinner G, Landmesse U, Brandes RP, Kubat B, Plasger J, Eberhard O, Koch KM, Olbricht CJ: Reactive oxygen species and antioxidant defense in puromycin aminonuclcoside glomerulopathy. J Am Soc Nephrol 1997;8:1722-1731.
11. Kakkar R, Manta SV, Radhi J, Prasad K, Kalra J: Antioxidant defense system in diabetic kidney: A time course study. Life Sci 1997;60: 667-679.
12. Reddi AS, Bollineni JS: Renal cortical expression of mRNAs for antioxidant enzymes in normal and diabetic rats. Biochem Biophys Res Commun 1997;235:598-601.
13. Tang Z, Shou I, Wang LN, Fukui M, Tomino Y: Effects of antihypertensive drugs or glycemic control on antioxidant enzyme activities in spontaneously hypertensive rats with diabetes. Nephron 1997;76:323-330.
14. Seehi LA, Ceriello A, Griffin CA, Catena C, Amstad P, Schambelan M, Bartoli E: Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus. Diabetologia 1997;40:23-29.
15. Durak I, Karabacak HI, Büyükkoçak S, Burak Cimen MY, Kaçmaz M, Omeroglu E, Oztürk HS: Impaired antioxidant defense system in the kidney tissues from rabbits treated with cyclosporine: Protective effects of vitamins E and C. Nephron 1998;78:207-211.
16. Wang LN, Fukui M, Shou I, Yaguchi Y, Funabiki K, Horikoshi S, Shirato I, Tomino Y: Detection of antioxidant enzyme activities in renal tissues of early stage IgA nephropathy in ddY mice. J Clin Lab Anal 1996;10:394-398.
17. Kavutcu M, Canholat O, Öztürk S, Olcay E, Ulutepe S, Ekinei C, Gökhun IH, Durak I: Reduced enzymatic antioxidant defense mechanism in kidney tissues from gentamicintreated guinea pigs: Effects of vitamines E and C. Nephron 1996;72:269-274.
18. Van den Branden C, Vameeq J, Verbeelen D, Roels F: In vivo hydrogen peroxide production in rat remnant kidney. Renal Physiol Biochem 1994;17:240-245.
19. Van den Branden C, Verelst R, Vameeq J, Vanden Houte K, Verbeelen D: Effect of vitamin E on antioxidant enzymes, lipid peroxidation products and glomerular sclerosis in rat remnant kidney. Nephron 1997;76:77-81.
20. Verbeelen DL, De Craemer D, Peeters P, Vanden Houte K, Van den Branden C: Enalapril increases antioxidant enzyme activity in renal cortical tissue of five-sixths-nephrectomized rats. Nephron 1998;80:214-219.
21. Van den Branden C, Gabriels M, Vamecq J, Vanden Houte K, Verbeelen D: Carvedilol protects against glomerulosclerosis in rat remnant kidney without general changes in antioxidant enzyme status: A comparative study of two beta-blocking drugs, carvedilol and propranolol. Nephron 1997;77:319-324.
22. Brenner BM: Nephron adaptation to renal injury or ablation. Am J Physiol 1985;249:F324-F337.
23. Spayd RW, Bruschi B, Burdick BA, Dappen GM, Eikenberry JN, Esders TW, Figueras J, Goodhue CT, LaRossa DD, Nelson RW, Rand RN, Wu T-W: Multilayer film elements for clinical analysis: Applications to representative chemical determinations. Clin Chem 1978; 1343-1350.
24. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC: Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-475.
25. Tilly JL, Tilly KI: Inhibitors of oxidative stress mimic the ability of follicle-stimulating hormone to suppress apoptosis in cultured rat ovarian follicles. Endocrinology 1995;136: 242-252.